A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma

NCT01171781 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Nasophayngeal Carcinoma Between Stage II and IVb

Interventions

DRUG: cisplatin (3 weekly)
DRUG: cisplatin (weekly)

Sponsor

Samsung Medical Center